Teladoc reports Q2 EPS (40c), consensus (41c)

Reports Q2 revenue $652.4M, consensus $649.19M. Jason Gorevic, CEO of Teladoc Health, said, “For the second quarter, we are pleased to report strong financial and operating results against all key metrics, including adjusted EBITDA of $72.2M, exceeding expectations. This performance is a direct result of introducing and expanding new products and services, investing in a robust innovation pipeline, controlling expenses, and vertically integrating care to capitalize on customer demand for unified virtual and in-person healthcare experiences.”